These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7623949)

  • 21. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas.
    Konstantinidou AE; Korkolopoulou P; Kavantzas N; Mahera H; Thymara I; Kotsiakis X; Perdiki M; Patsouris E; Davaris P
    Histol Histopathol; 2003 Jan; 18(1):67-74. PubMed ID: 12507285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive meningiomas in relation to high proliferating potential.
    Suwa T; Kawano N; Kameya T; Ito H; Oka H; Yada K
    Noshuyo Byori; 1993; 10(1):63-7. PubMed ID: 7693228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
    Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
    Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary resected meningiomas: relapses and proliferation markers.
    Kalala JP; Caemaert J; De Ridder L
    In Vivo; 2004; 18(4):411-6. PubMed ID: 15369177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
    Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
    Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting recurrence of intracranial meningiomas. A multivariate clinicopathologic model--interim report of the New York University Medical Center Meningioma Project.
    Miller DC
    Neurosurg Clin N Am; 1994 Apr; 5(2):193-200. PubMed ID: 8032222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grade zero removal of supratentorial convexity meningiomas.
    Perry JR; Cusimano MD
    Neurosurgery; 1994 Apr; 34(4):770-1; author reply 771. PubMed ID: 8054050
    [No Abstract]   [Full Text] [Related]  

  • 30. Meningioma: proliferating potential and clinicoradiological features.
    Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
    Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study.
    Takeuchi H; Kubota T; Kabuto M; Kitai R; Nozaki J; Yamashita J
    Surg Neurol; 1997 Nov; 48(5):501-6. PubMed ID: 9352816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning.
    Mantle RE; Lach B; Delgado MR; Baeesa S; Bélanger G
    J Neurosurg; 1999 Sep; 91(3):375-83. PubMed ID: 10470810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson grade IV resection.
    Fukushima Y; Oya S; Nakatomi H; Shibahara J; Hanakita S; Tanaka S; Shin M; Kawai K; Fukayama M; Saito N
    J Neurosurg; 2013 Dec; 119(6):1373-9. PubMed ID: 24053497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of proliferative indices in meningiomas.
    Hsu DW; Pardo FS; Efird JT; Linggood RM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1994 May; 53(3):247-55. PubMed ID: 7909837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.
    Fukui M; Iwaki T; Sawa H; Inoue T; Takeshita I; Kitamura K
    Acta Neurochir (Wien); 1986; 81(3-4):135-41. PubMed ID: 3529838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
    Panagopoulos AT; Lancellotti CL; Veiga JC; de Aguiar PH; Colquhoun A
    J Neurooncol; 2008 Aug; 89(1):73-87. PubMed ID: 18418552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
    Demirtaş E; Yilmaz F; Ovül I; Oner K
    Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.